Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$22.18 -3.25 (-12.78%)
At close: Sep 24, 2026 · 4:00 PM EDT

Acadia Pharmaceuticals (ACAD) Gross Margin (2016 - 2026)

Acadia Pharmaceuticals (ACAD) posted Gross Margin of 90.81% for Q2 2026, little changed on a QoQ basis from 90.75% in Q1 2026, and down 136.0% year-over-year from 252.24% in Q2 2025.

Analysis

Acadia Pharmaceuticals (ACAD) Gross Margin (2016 - 2026) Analysis & Trends

Acadia Pharmaceuticals has reported Gross Margin for 11 years, with the latest figure at 90.81% in Q2 2026.

  • On a quarterly basis, Gross Margin fell 136.0% year-over-year to 90.81% in Q2 2026; TTM through Jun 2026 was 91.13%, a 84.0% decrease from a year earlier, with the FY2025 full-year figure at 91.69%, up 24.0% from the prior year.
  • Gross Margin was 90.81% for Q2 2026 at Acadia Pharmaceuticals, roughly flat from 90.75% in the prior quarter.
  • The five-year high for Gross Margin was 98.59% in Q1 2023, with the low at 88.85% in Q1 2024.
  • Average Gross Margin over 5 years is 93.62%, with a median of 92.36% recorded in 2023.
  • The sharpest annual moves came in 2022 and 2024: Gross Margin jumped 645 bps in 2022, then tumbled 974 bps in 2024.
  • Over 5 years, Gross Margin stood at 98.23% in 2022, then decreased by 6 bps to 92.26% in 2023, then slipped by 1 bps to 91.6% in 2024, then retreated by 1 bps to 90.77% in 2025, then increased by 0 bps to 90.81% in 2026.
  • The last three Gross Margin figures came in at 90.81% (Q2 2026), 90.75% (Q1 2026), and 90.77% (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 68.19%
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 74.74%
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn 73.54%
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn 78.02%
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn 83.60%
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 72.04%
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn 79.76%
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn 85.33%
10 Acadia Pharmaceuticals 4.38 Bn 3.42 Bn 279.64 Mn 90.81%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 90.81%
Mar 31, 2026 90.75%
Dec 31, 2025 90.77%
Sep 30, 2025 92.23%
Jun 30, 2025 92.16%
Mar 31, 2025 91.65%
Dec 31, 2024 91.60%
Sep 30, 2024 92.47%
Jun 30, 2024 92.47%
Mar 31, 2024 88.85%
Dec 31, 2023 92.26%
Sep 30, 2023 93.09%
Jun 30, 2023 95.49%
Mar 31, 2023 98.59%
Dec 31, 2022 98.23%
Sep 30, 2022 98.37%
Jun 30, 2022 98.02%
Mar 31, 2022 97.45%
Dec 31, 2021 91.78%
Sep 30, 2021 97.20%
API Access

Acadia Pharmaceuticals Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=ACAD&period=max&api_key=YOUR_API_KEY